Edwards Lifesciences Corporation (EW)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 01:33PM EDT. Market open.
| Previous close | 65.71 |
| Open | 65.55 |
| Bid | 66.57 x 800 |
| Ask | 66.59 x 1000 |
| Day's range | 65.54 - 66.96 |
| 52-week range | 58.93 - 96.12 |
| Volume | |
| Avg. volume | 5,560,341 |
| Market cap | 40.108B |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | 26.21 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Edwards Lifesciences Completes Sale of Critical Care
IRVINE, Calif., September 03, 2024--Edwards Lifesciences (NYSE: EW) has successfully completed the sale of its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX) for $4.2 billion in an all-cash transaction. The net proceeds from the sale will be used to fund strategic initiatives including the previously announced acquisitions and share repurchases.
- Business Wire
CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
LONDON, August 31, 2024--Please replace the release with the following corrected version.
- Business Wire
Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
IRVINE, Calif., August 21, 2024--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the Wells Fargo Healthcare Conference on Thursday, Sept. 5, 2024.
© 2024 Yahoo. All rights reserved.